Diversity in Clinical Trials: Significance & Challenges
Diversity in Clinical Trials: Significance & Challenges By Jan Filakovsky, CEO of Biomapas Diversity in clinical trials is crucial in ensuring that research findings are broadly applicable, and in avoiding treatments that are ineffective or even harmful to...
Unlocking Success: The FSP Advantage in Clinical Research
The Functional Service Provider (FSP) models in clinical research are becoming increasingly appealing to the pharmaceutical and biotechnology sectors, offering flexible and scalable solutions to outsource specific functions . Currently pharmaceutical and...
Literature monitoring of Pharmacovigilance in realities of war in Ukraine
It is fascinating to observe how the realities of war have affected the way in which the literature monitoring of Pharmacovigilance is carried out in Ukraine. The need for continuous monitoring of drug safety in a country at war, and the ability to adapt to the...





